WallStreetZenWallStreetZen

NASDAQ: CNTA
Centessa Pharmaceuticals PLC Earnings & Revenue

CNTA earnings and revenue history

Current Revenue
$6.9M
Current Earnings
-$151.1M
Current Profit Margin
-2,204.7%

CNTA Return on Equity

Current Company
-56.7%
Current Industry
-63.5%
Current Market
188%
CNTA's Return on Equity (-56.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CNTA announces earnings.

CNTA Return on Assets

Current Company
-39.4%
Current Industry
2.9%
CNTA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CNTA Return on Capital Employed

Current Company
-51.81%
Current Industry
19.5%
CNTA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CNTA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CNTA$6.85M-$165.43M-$151.09MN/AN/A
PHVS$0.00-$103.93M-$108.47MN/AN/A
MNKD$198.96M$20.62M-$11.94M+48.17%N/A
EYPT$46.02M-$69.00M-$70.80M+58.70%N/A
MIRM$186.37M-$135.87M-$163.42M+212.06%N/A

CNTA earnings dates

Next earnings date
May 13, 2024

Centessa Pharmaceuticals Earnings & Revenue FAQ

What were CNTA's earnings last quarter?

On Invalid Date, Centessa Pharmaceuticals (NASDAQ: CNTA) reported Q4 2023 earnings per share (EPS) of -$0.37, up 17.78% year over year. Total Centessa Pharmaceuticals earnings for the quarter were -$36.84 million. In the same quarter last year, Centessa Pharmaceuticals's earnings per share (EPS) was -$0.45.

If you're new to stock investing, here's how to buy Centessa Pharmaceuticals stock.

What was CNTA's earnings growth in the past year?

As of Q2 2024, Centessa Pharmaceuticals's earnings has grown year over year. Centessa Pharmaceuticals's earnings in the past year totalled -$151.09 million.

What is CNTA's earnings date?

Centessa Pharmaceuticals's earnings date is Invalid Date. Add CNTA to your watchlist to be reminded of CNTA's next earnings announcement.

What was CNTA's revenue last quarter?

On Invalid Date, Centessa Pharmaceuticals (NASDAQ: CNTA) reported Q4 2023 revenue of $6.85 million up Infinity% year over year. In the same quarter last year, Centessa Pharmaceuticals's revenue was $0.00.

What was CNTA's revenue growth in the past year?

As of Q2 2024, Centessa Pharmaceuticals's revenue has grown null year over year. Centessa Pharmaceuticals's revenue in the past year totalled $6.85 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.